Nutritional Considerations in Pediatric Inflammatory Bowel Disease
Overview
Authors
Affiliations
Nutrition is a critical part of the management of inflammatory bowel disease (IBD) in children and adults. Malnutrition and micronutrient deficiencies are common at the time of diagnosis and may persist throughout the course of the disease. There are a number of similarities with regards to the nutritional complications and the approach to nutritional management in IBD in both children and adults, but there are also important differences. Growth failure, pubertal delay and the need for corticosteroid-sparing regimens are of higher importance in pediatrics. In the pediatric population, exclusive enteral nutrition may be equivalent to corticosteroids in inducing remission in acute Crohn's disease, and may have benefits over corticosteroids in children. Adherence with exclusive enteral nutrition is better in children than in adults. Iron deficiency anemia is an important problem for adults and children with IBD. Intravenous iron administration may be superior to oral iron supplementation. Ensuring adequate bone health is another critical component of nutritional management in IBD, but guidelines for screening and therapeutic interventions for low bone mineral density are lacking in children.
Evaluation of Growth in Children with Inflammatory Bowel Disease.
Altas U, Ertem D Children (Basel). 2024; 11(9).
PMID: 39334571 PMC: 11429859. DOI: 10.3390/children11091038.
Vernon-Roberts A, Day A JGH Open. 2024; 8(3):e13041.
PMID: 38444634 PMC: 10910611. DOI: 10.1002/jgh3.13041.
Growth and Puberty in Children with Inflammatory Bowel Diseases.
Amaro F, Chiarelli F Biomedicines. 2020; 8(11).
PMID: 33138015 PMC: 7692295. DOI: 10.3390/biomedicines8110458.
Effectiveness of Mediterranean Diet's Adherence in children with Inflammatory Bowel Diseases.
Strisciuglio C, Cenni S, Serra M, Dolce P, Martinelli M, Staiano A Nutrients. 2020; 12(10).
PMID: 33092159 PMC: 7589768. DOI: 10.3390/nu12103206.
Vernon-Roberts A, Otley A, Frampton C, Gearry R, Day A Inflamm Intest Dis. 2020; 5(2):70-77.
PMID: 32596257 PMC: 7315219. DOI: 10.1159/000506200.